Correlation Between Tenaya Therapeutics and LMF Acquisition

Can any of the company-specific risk be diversified away by investing in both Tenaya Therapeutics and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenaya Therapeutics and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tenaya Therapeutics and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Tenaya Therapeutics and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenaya Therapeutics with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenaya Therapeutics and LMF Acquisition.

Diversification Opportunities for Tenaya Therapeutics and LMF Acquisition

0.08

Correlation Coefficient

Tenaya Therapeutics  LMF Acquisition

Significant diversification

The 3 months correlation between Tenaya and LMF is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tenaya Therapeutics and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Tenaya Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenaya Therapeutics are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Tenaya Therapeutics i.e., Tenaya Therapeutics and LMF Acquisition go up and down completely randomly.

Pair Corralation between Tenaya Therapeutics and LMF Acquisition

Given the investment horizon of 90 days Tenaya Therapeutics is expected to generate 4.02 times less return on investment than LMF Acquisition. But when comparing it to its historical volatility, Tenaya Therapeutics is 1.32 times less risky than LMF Acquisition. It trades about 0.02 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3.76  in LMF Acquisition Opportunities on October 22, 2024 and sell it today you would lose (0.66) from holding LMF Acquisition Opportunities or give up 17.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tenaya Therapeutics  vs.  LMF Acquisition Opportunities

Tenaya Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Tenaya Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Tenaya Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

LMF Acquisition Oppo

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in LMF Acquisition Opportunities are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, LMF Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tenaya Therapeutics and LMF Acquisition

The main advantage of trading using opposite Tenaya Therapeutics and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenaya Therapeutics position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.

The idea behind Tenaya Therapeutics and LMF Acquisition Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.